Hepatocyte growth factor/scatter factor suppresses TNF-α-induced E-selectin expression in human umbilical vein endothelial cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1644, Issue 1, 2004, Pages 9-15

  Makondo, Kennedy ^a   Kimura, Kazuhiro ^a   Kitamura, Takanori ^a   Yamaji, Daisuke ^a   Jung, Bae Dong ^a   Shibata, Haruki ^b   Saito, Masayuki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b 2 1 1 Shimosueyoshi   (Japan)

Author keywords

Cell adhesion molecule; E selectin; eNOS; HGF SF; L NAME; Nitric oxide

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SCATTER FACTOR; TUMOR NECROSIS FACTOR;

ARTICLE; CELL ADHESION; CELL INTERACTION; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEART PROTECTION; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; UMBILICAL VEIN;

EID: 1642442540     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2003.10.006     Document Type: Article

References (32)

1. Grierson I., Heathcote L., Hiscott P., Hogg P., Briggs M., Hagan S. Hepatocyte growth factor/scatter factor in the eye. Prog. Ret. Eye Res. (19):2000;779-802.
2. Bussolino F., Di Renzo M.F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Comoglio P.M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119:1992;629-641.
3. Rosen E.M., Lamszus K., Laterra J., Polverini P.J., Rubin J.S., Goldberg I.D. HGF/SF in angiogenesis. Ciba Found. Symp. 212:1997;215-226.
4. Maulik G., Shrikhande A., Kijima T., Ma P.C., Morrison P.T., Salgia R. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev. 13:2002;41-59.
5. Kawakami-Kimura N., Narita T., Ohmori K., Yoneda T., Matsumoto K., Nakamura T., Kannagi R. Involvement of hepatocyte growth factor in increased integrin expression on HepG2 cells triggered by adhesion to endothelial cells. Br. J. Cancer. 75:1997;47-53.
6. Derman M.P., Cunha M.J., Barros E.J., Nigam S.K., Cantley L.G. HGF-mediated chemotaxis and tubulogenesis require activation of the phophatidylinositol 3-kinase. Am. J. Physiol. 268:1995;F1211-F1217.
7. Nakagami H., Morishita R., Yamamoto K., Taniyama Y., Aoki M., Matsumoto K., Nakamura T., Kaneda Y., Horiuchi M., Ogihara T. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3 and Akt in endothelial cells. Hypertension. 37:2001;581-586.
8. Jugdutt B.I. Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail. Rev. 7:2002;391-405.
9. Williams I.L., Wheatcroft S.B., Shah A.M., Kearney M.T. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int. J. Obes. 26:2002;754-764.
10. Price D.T., Loscalzo J. Cellular adhesion molecules and atherogenesis. Am. J. Med. 107:1999;85-97.
11. De Caterina R. Endothelial dysfunctions: common denominators in vascular disease. Curr. Opin. Clin. Nutr. Metab. Care. 3:2000;453-467.
12. Glass C.K., Witztum J.L. Atherosclerosis: the road ahead. Cell. 104:2001;503-516.
13. Adams D.H., Harvath L., Bottaro D.P., Interraante R., Catalano G., Tanaka Y., Strain A., Hubscher S.G. Hepatocyte growth factor and macrophage inflammatory protein 1β: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. Proc. Natl. Acad. Sci. U. S. A. 91:1994;7144-7148.
14. Mine S., Tanaka Y., Suematu M., Aso M., Fujisaki T., Yamada S., Eto S. Hepatocyte growth factor is a potent trigger of neutrophil adhesion through rapid activation of lymphocyte function-associated antigen-1. Lab. Invest. 78:1998;1395-1404.
15. Yasuda S., Goto Y., Baba T., Satoh T., Sumida H., Miyazaki S., Nonogi H. Single low-dose administration of human recombinant hepatocyte growth factor attenuates intimal hyperplasia in a ballon-injured rabbit iliac artery model. J. Am. Coll. Cardiol. 36:2000;115-121.
16. Miyagawa S., Sawa Y., Taketani S., Kawaguchi N., Nakamura T., Matsuura N., Matsuda H. Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation. 105:2002;2556-2561.
17. Ono K., Mastumori A., Shioi T., Furukawa Y., Sasayama S. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation. 95:1997;2552-2558.
18. Ueda H., Nakamura T., Matsumoto K., Sawa Y., Matsuda H., Nakamura T. A potential role of hepatocyte growth factor in myocardial infarction in rats. Cardiovasc. Res. 51:2001;41-50.
19. Haug C., Schmid-Kotsas A., Zorn U., Bachem M.G., Schuett S., Gruenert A., Rozdzinski E. Hepatocyte growth factor is upregulated by low density liproteins and inhibits endothelin-1 release. Am. J. Physiol. 279:2000;H2865-H2871.
20. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y. Novel modulator for endothelial adhesion molecules adipocyte-derived plasma protein adiponectin. Circulation. 100:1999;2473-2476.
21. De Clerck L.S., Bridts C.H., Mertens A.M., Moens M.M., Stevens W.J. Use of fluorescent dyes in the determination of adherence of human leucocytes to endothelial cells and the effect of fluorochromes on cellular function. J. Immunol. Methods. 172:1994;115-124.
22. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
23. Hisamoto K., Ohmichi M., Kurachi H., Hayakawa J., Kanda Y., Nishio Y., Adachi K., Tasaka K., Miyoshi E., Fujiwara N., Taniguchi N., Murata Y. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J. Biol. Chem. 276:2001;3459-3467.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
25. Purdie K.J., Whitley G.S.J., Johnstone A.P., Cartwright J.E. Hepatocyte growth factor-induced endothelial cell motility is mediated by the upregulation of inducible nitric oxide synthase expression. Cardiovasc. Res. 54:2002;659-668.
26. De Caterina R., Libby P., Peng H.-B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A., Shin W.S., Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammation cytokines. J. Clin. Invest. 96:1995;60-68.
27. Dong Z.M., Chapman S.M., Brown A.A., Frenette P.S., Hynes R.O., Wagner D.D. The combined role of P- and E-selectin in atherosclerosis. J. Clin. Invest. 102:1998;145-152.
28. Loscalzo J., Welch G. Nitric oxide and its role in the cardiovascular system. Prog. Cardiovasc. Dis. 38:1995;87-104.
29. Makondo K., Kimura K., Kitamura N., Kitamura T., Yamaji D., Jung B.D., Saito M. Hepatocyte growth factor activates endothelial nitric oxide synthase by Ca2+- and phosphoinositide 3-kinase/Akt-dependent phosphorylation in aortic endothelial cells. Biochem. J. 374:2003;63-69.
30. Zadeh M.S., Kolb J.-P., Geromin D., D'Anna R., Boulmerka A., Marconi A., Dugas B., Marsac C., D'Alessio P. Regulation of ICAM-1/CD54 expression on human endothelial cells by hydrogen peroxide involves inducible NO synthase. J. Leukoc. Biol. 67:2000;327-334.
31. Chen Q., DeFrances M.C., Zarnaegar R. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation. Cell Growth Differ. 7:1996;821-832.
32. Galimi F., Cottone E., Vigna E., Arena N., Boccaccio C., Giordano S., Naldini L., Comoglio P.M. Hepatocyte growth factor is a regulator of monocyte-macrophage function. J. Immunol. 166:2001;1241-1247.